AU2012203172A1 — Novel compounds and compositions and methods of use
Assigned to Ardea Biociences Inc · Expires 2012-06-21 · 14y expired
What this patent protects
Novel Compounds and Compositions and Methods of Use Abstract [00425] Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the trea…
USPTO Abstract
Novel Compounds and Compositions and Methods of Use Abstract [00425] Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.
Drugs covered by this patent
- Aloprim (ALLOPURINOL) · Casper Pharma Llc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.